These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 406785)

  • 1. Compatibility of common additives in protein hydrolysate/dextrose solutions.
    Kobayashi NH; King JC
    Am J Hosp Pharm; 1977 Jun; 34(6):589-94. PubMed ID: 406785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility and stability of electrolytes, vitamins and antibiotics in combination with 8% amino acids solution.
    Schuetz DH; King JC
    Am J Hosp Pharm; 1978 Jan; 35(1):33-44. PubMed ID: 623116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefoxitin sodium compatibility with intravenous infusions and additives.
    O'Brien MJ; Portnoff JB; Cohen EM
    Am J Hosp Pharm; 1979 Jan; 36(1):33-8. PubMed ID: 31790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility considerations in parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW
    Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of calcium chloride and calcium gluconate with sodium phosphate in a mixed TPN solution.
    Henry RS; Jurgens RW; Sturgeon R; Athanikar N; Welco A; Van Leuven M
    Am J Hosp Pharm; 1980 May; 37(5):673-4. PubMed ID: 6770681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intropin (dopamine hydrochloride) intravenous admixture compatibility, Part 3: stability with miscellaneous additives.
    Gardella LA; Kesler H; Amann A; Carter JE
    Am J Hosp Pharm; 1978 May; 35(5):581-4. PubMed ID: 655182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drug additives.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Plitz GW; Cutie AJ
    Am J Hosp Pharm; 1982 Jun; 39(6):1013-5. PubMed ID: 7102682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of insulin from parenteral nutrient solutions.
    Weber SS; Wood WA; Jackson EA
    Am J Hosp Pharm; 1977 Apr; 34(4):353-7. PubMed ID: 404875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
    Perentesis GP; Piltz GW; Kirshcenbaum HL; Navalakha P; Aronoff W; Cutie AJ
    Am J Hosp Pharm; 1983 Jun; 40(6):1010-2. PubMed ID: 6869385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual compatibility of 30 additives with a parenteral nutrient solution.
    Athanikar N; Boyer B; Deamer R; Harbison H; Henry RS; Jurgens R; Mett C; Sturgeon R; VanLeuven M; Welco A
    Am J Hosp Pharm; 1979 Apr; 36(4):511-3. PubMed ID: 107797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous solution compatibility and filter-retention characteristics of trace-element preparations.
    Boddapati S; Yang K; Murty R
    Am J Hosp Pharm; 1981 Nov; 38(11):1731-6. PubMed ID: 6795924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hypercalcemia on serum concentrations of magnesium, potassium, and phosphate and urinary excretion of electrolytes in horses.
    Toribio RE; Kohn CW; Rourke KM; Levine AL; Rosol TJ
    Am J Vet Res; 2007 May; 68(5):543-54. PubMed ID: 17472456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium and phosphorus compatibility in parental nutrition solutions for neonates.
    Eggert LD; Rusho WJ; MacKay MW; Chan GM
    Am J Hosp Pharm; 1982 Jan; 39(1):49-53. PubMed ID: 6798868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrolyte compatibility in a synthetic amino acid hyperalimentation solution.
    Kaminski MV; Harris DF; Collin CF; Sommers GA
    Am J Hosp Pharm; 1974 Mar; 31(3):244-6. PubMed ID: 4206614
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth of bacteria and fungi in parenteral nutrition solutions containing albumin.
    Mirtallo JM; Caryer K; Schneider PJ; Ayers L; Fabri PJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1907-10. PubMed ID: 6798862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection.
    Strom JG; Miller SW
    Am J Hosp Pharm; 1991 Jun; 48(6):1237-41. PubMed ID: 1858803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of Liposyn II fat emulsion in total nutrient admixtures.
    Sayeed FA; Johnson HW; Sukumaran KB; Raihle JA; Mowles DL; Stelmach HA; Majors KR
    Am J Hosp Pharm; 1986 May; 43(5):1230-5. PubMed ID: 3087165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of esmolol hydrochloride in the presence of aminophylline, bretylium tosylate, heparin sodium, and procainamide hydrochloride.
    Schaaf LJ; Robinson DH; Vogel GJ; Wulf BG; Drda KD; Moses JO
    Am J Hosp Pharm; 1990 Jul; 47(7):1567-71. PubMed ID: 2368749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium and phosphate solubility curves for parenteral nutrient solutions containing Vaminolact.
    Mo-Suwan L; Puetpaiboon A; Apiromrak B
    J Med Assoc Thai; 1997 Aug; 80(8):516-20. PubMed ID: 9277084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutions.
    Bullock L; Parks RB; Lampasona V; Mullins RE
    Am J Hosp Pharm; 1985 Dec; 42(12):2683-7. PubMed ID: 3936354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.